Arkolith/Insider Trading/TRDA/Form 4

Wentworth Kory James

Chief Financial OfficerEntrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed Mar 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$214K
Net Open-Market Flow
-$214K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)11K$13.02$148K122K
Mar 9, 2026Sell(S)5K$13.00$66K133K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001725663-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML